MSL
TNDM icon

Mackay Shields LLC’s Tandem Diabetes Care TNDM Stock Holding History

Mackay Shields LLC’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-23,000
Closed -$1.48M – 1585
2020
Q1 		$1.48M Buy
+23,000
New +$1.61M 0.01% 796
2019
Q4 		– Sell
-75,800
Closed -$4.47M – 1464
2019
Q3 		$4.47M Sell
75,800
-5,200
-6% -$332K 0.03% 544
2019
Q2 		$5.23M Buy
+81,000
New +$5.23M 0.04% 507

Other funds holding TNDM

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Mackay Shields LLC's TNDM Position: Q2 2020 in Review

Mackay Shields LLC sold out of Tandem Diabetes Care (TNDM) in Q2 2020, closing a stake of 23,000 shares — an estimated $1.48M sold.

Mackay Shields LLC first reported a position in TNDM in Q2 2019 and held it in 3 quarters. The position peaked at $5.23M in Q2 2019. 303 funds tracked by Wall St. Rank hold TNDM as of Q2 2020.

  • Mackay Shields LLC reported no remaining Tandem Diabetes Care position as of Q2 2020 after selling out during the quarter.
  • Mackay Shields LLC sold 23,000 Tandem Diabetes Care shares in Q2 2020, an estimated $1.48M.
  • Mackay Shields LLC first reported a position in Tandem Diabetes Care in Q2 2019 and held it in 3 quarters.
  • Mackay Shields LLC's Tandem Diabetes Care position peaked at $5.23M in Q2 2019.
  • 303 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2020.

Based on Mackay Shields LLC's 13F filing for Q2 2020, filed 31 Jul 2020.